These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9224504)

  • 1. Use of novel beta-L(-)-nucleoside analogues for treatment and prevention of chronic hepatitis B virus infection and hepatocellular carcinoma.
    Bridges EG; Cheng YC
    Prog Liver Dis; 1995; 13():231-45. PubMed ID: 9224504
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hepatitis B].
    Telegdy L
    Orv Hetil; 2004 Nov; 145(45):2293-6. PubMed ID: 15573894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus: old, new and future approaches to antiviral treatment.
    Karayiannis P
    J Antimicrob Chemother; 2003 Apr; 51(4):761-85. PubMed ID: 12654750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of hepatocellular carcinoma: the holy grail of hepatitis B treatment.
    Sherman M
    J Hepatol; 2009 May; 50(5):854-6. PubMed ID: 19303162
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of hepatocellular carcinoma.
    Craxì A; Cammà C
    Clin Liver Dis; 2005 May; 9(2):329-46, viii. PubMed ID: 15831277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological and anti-viral therapy of chronic hepatitis B virus infection.
    Thomas HC; Bassendine MF
    Clin Gastroenterol; 1980 Jan; 9(1):85-95. PubMed ID: 6156790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis B and the prevention of hepatocellular carcinoma].
    Blumberg BS
    Nouv Presse Med; 1982 Mar; 11(12):903-5. PubMed ID: 6278399
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing infection-associated cancer: from bench to hillside.
    Goedert JJ
    J Natl Cancer Inst; 2005 Feb; 97(4):245-6. PubMed ID: 15713953
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis B virus (HBV) infection and hepatocarcinogenesis].
    Pár A
    Orv Hetil; 2010 Jun; 151(26):1045-53. PubMed ID: 20558351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of hepatocellular carcinogenesis by interferon].
    Ikeda K
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():755-63. PubMed ID: 11762051
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical significance of interferon therapy in treatments for hepatitis C virus-related hepatocellular carcinoma].
    Kubo S; Nishiguchi S; Hirohashi K; Tanaka H; Shuto T; Takemura S; Shiomi S; Kinoshita H
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):1975-9. PubMed ID: 11791377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hepatitis B and C -- current standards].
    Zeuzem S
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S57-9. PubMed ID: 15368169
    [No Abstract]   [Full Text] [Related]  

  • 13. [Modern strategy in the treatment of chronic hepatitis B: progress and prospects].
    Isakov VA
    Eksp Klin Gastroenterol; 2007; (2):107-12. PubMed ID: 17539354
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic hepatitis C virus infection: always treat!--Pro].
    Zeuzem S
    Dtsch Med Wochenschr; 2002 Sep; 127(36):1840. PubMed ID: 12215931
    [No Abstract]   [Full Text] [Related]  

  • 15. [Does interferon therapy on type C liver cirrhosis prevent the occurrence of hepatocellular carcinoma?].
    Harada H; Iga D; Arisaka Y; Mitsuhashi Y; Kamitsukasa H; Yagura M; Endou H; Kawashima H
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):754-8. PubMed ID: 7563870
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferons in the management of viral hepatitis.
    Zein NN
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
    Liaw YF
    Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
    Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
    Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
    Testino G; Ansaldi F; Andorno E; Ravetti GL; Ferro C; De Iaco F; Icardi G; Valente U
    Hepatogastroenterology; 2002; 49(48):1636-8. PubMed ID: 12397752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telbivudine/Torcitabine Idenix/Novartis.
    Hodge RA
    Curr Opin Investig Drugs; 2004 Feb; 5(2):232-41. PubMed ID: 15043399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.